Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

Donate
  • ABOUT THE FOUNDATION
    • Agi’s Story
    • About Us →
      • Mission
      • Directors/Trustees
      • Scientific Advisory Board
      • Our History
    • COVID-19 Resources
    • News →
      • Newsletters
      • Breaking News
      • Press Room
    • Contact
  • PANCREATIC CANCER
    • About the Pancreas →
      • The Pancreas
      • Cancer Cells
      • Risk Factors
      • Symptoms
      • Diagnosis
      • Prognosis
      • Staging
      • Second Opinion
    • Treatment Options →
      • Surgery
      • Chemotherapy
      • Targeted Therapy
      • Radiation Therapy
      • Alternative Treatment Options
      • Clinical Trials
    • Supportive Care →
      • Obstructions
      • Pain Control
      • Nutrition
      • Cannabis
      • Palliative Care
    • Pancreatic Cancer Facts
    • Glossary of Terms
    • Frequently Asked Questions
  • RESEARCH
    • Seed Grant Program →
      • Seed Grant Recipients
      • Frequently Asked Questions
    • UCLA Program →
      • UCLA Center for Pancreatic Diseases
      • Basic Research
      • Translational Research
      • Sahin-Toth Laboratory
      • UCLA Pancreas Tissue Bank
      • Simms/Mann Psychosocial →
        • Insights into Cancer
    • American Pancreatic Association
    • NIH Funded Projects
  • PATIENTS & CAREGIVERS
    • Patient Support
    • Symposium
    • Symposium Presentations
    • Patient & Family Webinars
    • Financial Aid
    • Tools →
      • Symptom Management Workbook
      • Cancer of the Pancreas Booklet
      • Advice for Caregivers
      • Creating Your Health Care Team
      • A Virtual Advocate
  • HOW YOU CAN HELP
    • You Can Help Funds
    • Host Your Own Event
    • Event Calendar
    • Get Inspired
    • November Awareness Month →
      • World Pancreatic Cancer Day
    • Other Ways to Give →
      • Shop Online Store
      • Wedding Program
      • Volunteer
      • Shop AmazonSmile
      • Car Program
  • SEARCH
Home / Symposium Speaker Spotlight / Symposium Speaker Spotlight: Dr. Timothy Donahue to speak on Personalized Medicine & Tumor Testing

Symposium Speaker Spotlight: Dr. Timothy Donahue to speak on Personalized Medicine & Tumor Testing

Timothy Donahue, MD, Chief of the division of Surgical Oncology at the UCLA David Geffen School of Medicine to speak at the 15th Annual Symposium on Pancreatic Cancer

February 13, 2019

The Hirshberg Foundation is excited to welcome Dr. Donahue to the 15th Annual Symposium on Pancreatic Cancer to discuss personalized medicine and tumor testing.

Dr. Timothy Donahue attended Northwestern University where he received both his Bachelor’s degree and Medical degree. Upon completion, he continued his surgical and research training at UCLA. In 2009, he was appointed faculty and has made strides at UCLA ever since.

Dr. Donahue is a Professor of Surgery at the David Geffen School of Medicine at UCLA. He has a joint appointment in the Department of Molecular and Medical Pharmacology to facilitate his research program. Dr. Donahue is the Chief of the Division of Surgical Oncology and Vice Chair for Cancer Surgery in the Department of Surgery. In this role, he oversees all of cancer surgery including the pancreatic cancer program, which is one of the largest in the nation. Dr. Donahue is a valuable part of the surgical team at the UCLA Agi Hirshberg Center for Pancreatic Diseases. In addition, Dr. Donahue is also the Program Director of the General Surgery Residency Program at UCLA.

Dr. Donahue is a very busy pancreatic surgeon who works diligently performing up to three pancreatic surgeries per week. He is especially interested in caring for patients with pancreatic cancer. His clinical research is focused on improving the care of patients with borderline resectable or locally advanced disease. Dr. Donahue is a strong advocate of prolonged preoperative chemo or radiation therapy for this group of patients to optimally select for those who will benefit from a surgical resection. As a result of this approach, Dr. Donahue and his team have among the best survival rates that have been reported. In addition to his clinical work, Dr. Donahue is the Principal Investigator of a National Institutes of Health funded research laboratory. His scientific research focuses on developing improved treatment strategies and earlier diagnostic markers for patients with pancreatic cancer. He collaborates closely with other scientists across the UCLA campus, including faculty in the Ahmanson Translational Imaging Division and California Nanosystems Institute. He is optimistic that therapy for pancreatic cancer will markedly improve during his career.

Dr. Donahue will speak on Personalized Medicine and Tumor Testing along with fellow surgeon Dr. Joe Hines.

Filed Under: News, Symposium Speaker Spotlight

Study on Feasibility of Nursing Intervention to Reduce Pain, Depression & Fatigue for Pancreatic Cancer Patients Seeks Volunteers
Symposium Speaker Spotlight: Dr. Joe Hines to discuss Personalized Medicine & Tumor Testing

Patient Support Resources

from the comfort of your home


Our Webinar Library »

We bring new meaning to the words
Never Give Up.
Our Stories »
SUBSCRIBE
Our Free E-Newsletter
Sign up to receive information on breaking news, patient programs and upcoming events.
You can custom tailor your subscriptions and unsubscribe at any time.
  • How You Can Help
  • Make A Donation
  • Host an Event
  • Shop Online Store
  • Signature Events
  • L.A. Cancer Challenge
  • Tour De Pier
  • Hirshberg Training Team
  • More
  • News
  • Press
  • Contact

Stay Connected

  • Facebook
  • Twitter
  • YouTube
  • Vimeo

Join Our E-newsletter

  • Legal and Privacy
  • Contact Us
Keeping Patients Safe & Never Giving Up on a Cure
WATCH WEBINAR SERIES